Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Sharyn D. Baker, Ming Zhao, Carlton K.K. Lee, Jaap Verweij, Yelena Zabelina, Julie R. Brahmer, Antonio C. Wolff, Alex Sparreboom, Michael A. Carducci

Clinical Cancer Research · 2004 · 125 citations · 43 references

Abstract

Docetaxel pharmacokinetics are similar for the weekly and 3-weekly regimens. Prolonged circulation of low nanomolar concentrations of docetaxel may contribute to the mechanism of action of docetaxel through suppression of microtubule dynamics and tumor angiogenesis and enhanced cell radiosensitivity in combined modality therapy.

References

43